Blood test breakthrough? new study hopes to sniff out liver cancer early.
NCT ID NCT07148310
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing a new blood test called delta-HLD to see if it can accurately detect liver cancer (hepatocellular carcinoma). Researchers will compare blood and tissue samples from 200 people, half with liver cancer and half with liver cirrhosis but no cancer. If the test works well, it could offer a less invasive way to catch liver cancer earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
delta-HLD liquid biopsy test
What this could lead to
If successful, this could lead to a simple blood test for early detection of liver cancer, potentially improving survival rates.
What could go wrong
This is a small, early-stage study. The test may not be accurate enough, and results may not apply to all patients or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATO CELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Epiliquid
RECRUITINGMendoza, 5500, Argentina
Contact Phone: •••-•••-•••• Email: •••••@•••••